Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a company in Petach Tivka, Israel that has taken part in 12 EU-funded projects since 2017, receiving €260k in EU funding.

EU funding received€260k
EU projects12
As coordinator0
Running now3
First EU project2017
Latest project2025
CountryIsrael
EU registration (PIC)923869808
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Teva Pharmaceutical Industries Limited's own share of each project, not the project's full budget.

  • Horizon 2020€260k · 11 projects
  • Horizon Europe€0 · 1 project

Projects

12 EU-funded projects, newest first. Each links to the official record.

  • BRIDGEPartner

    Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • EPNDPartner

    European platform for neurodegenerative disorders

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • RealHOPEPartner

    Real World Handling of Protein Drugs - Exploration, Evaluation and Education

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • EU-PEARLPartner

    EU Patient- cEntric clinicAl tRial pLatform

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • Trials@HomePartner

    Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

  • MOBILISE-DPartner

    Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • ConcePTIONPartner

    Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • PD-MitoQUANTPartner

    PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • AIMS-2-TRIALSPartner

    Autism Innovative Medicine Studies – 2 – Trials

    Horizon 2020 · 2018–2026 · Project on CORDIS ↗

  • IMI-PainCarePartner

    Improving the care of patients suffering from acute or chronic pain

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • THERACATPartner

    Bio-orthogonal catalysis for cancer therapy

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €260ktheir share
  • EQIPDPartner

    European Quality In Preclinical Data

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alzheimer
  • biochemistry
  • catalysis
  • data science
  • drug discovery
  • entrepreneurship
  • epilepsy
  • governance
  • machine learning
  • neurobiology
  • obstetrics
  • oncology
  • parkinson
  • pathophysiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime